Please login to the form below

Not currently logged in
Email:
Password:

The Partners appoints new creative director

Award-winning Peter Henshaw joins from InVentive Europe

Peter Henshaw The PartnersBrand consultancy The Partners has appointed award-winning Creative Director Peter Henshaw to lead the creative offer for the agency's Health Team.

Henshaw will lead global relationships with Novo Nordisk, AstraZeneca, The International Aids Society, among others.

He has more than 20 years' experience in branding and advertising specialising in behaviour change and most recently worked as a creative director at InVentive Europe. 

Henshaw has also advised government departments, pharma companies and the food and drinks industry on healthcare communications. 

Margaret Wolhuter, managing director of The Partners Health, said: “I am confident that Peter has the insight, creativity and expertise needed to be a key driver in growing our client's brands, helping build the lasting emotional connections with people that ultimately drive changes in behaviour.”

Henshaw is also a judge of international creativity and advertising, and has been on the Grand Jury of Cannes Lions and New York Festivals.

15th July 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics